FindTrial
Sign In

Effect of age on 95% effective dose of remimazolam for loss of consciousness during anesthesia induction

Effect of age on 95% effective dose of remimazolam for loss of consciousness during anesthesia induction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006866
Enrollment
120
Registered
2021-12-23
Start date
2021-12-31
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ajou University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Adult patients aged 20-79 who are scheduled to undergo general anesthesia

Exclusion criteria

Exclusion criteria: In the case of BMI > 30 kg/m2 or < 20 kg/m2, patients with contraindications such as allergies, hearing impairment, etc., making it difficult to respond to oral orders from researchers, and taking other drugs that may affect the effectiveness of benzodiazepine drugs.

Design outcomes

Primary

MeasureTime frame
The difference between anesthesia induction of age in dose.—

Secondary

MeasureTime frame
Hemodynamics (average arterial pressure, pulse rate, oxygen saturation) data and BIS levels.—

Countries

Korea, Republic of

Contacts

Public ContactSung Yong Park

Ajou University Hospital

anepark@hanmail.net+82-31-219-5573

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026